Pages that link to "Q8014179"
Jump to navigation
Jump to search
The following pages link to William L. Jorgensen (Q8014179):
Displayed 50 items.
- Elias James Corey (Q135171) (← links)
- Journal of Chemical Information and Modeling (Q3007982) (← links)
- Comparison of simple potential functions for simulating liquid water (Q26778447) (← links)
- Exploiting Structural Analysis, in Silico Screening, and Serendipity To Identify Novel Inhibitors of Drug-Resistant Falciparum Malaria (Q27653434) (← links)
- Discovery of Novel Fibroblast Growth Factor Receptor 1 Kinase Inhibitors by Structure-Based Virtual Screening (Q27659340) (← links)
- A remote arene-binding site on prostate specific membrane antigen revealed by antibody-recruiting small molecules (Q27664106) (← links)
- Small-Molecule Inhibitors of the Interaction between the E3 Ligase VHL and HIF1α (Q27674529) (← links)
- Crystal Structures of HIV-1 Reverse Transcriptase with Picomolar Inhibitors Reveal Key Interactions for Drug Design (Q27675166) (← links)
- Targeting the von Hippel–Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1α Interaction (Q27677509) (← links)
- Extension into the entrance channel of HIV-1 reverse transcriptase—Crystallography and enhanced solubility (Q27679282) (← links)
- Picomolar Inhibitors of HIV Reverse Transcriptase Featuring Bicyclic Replacement of a Cyanovinylphenyl Group (Q27680431) (← links)
- Structure-Based Evaluation of C5 Derivatives in the Catechol Diether Series Targeting HIV-1 Reverse Transcriptase (Q27680709) (← links)
- A mechanistic and structural investigation of modified derivatives of the diaryltriazine class of NNRTIs targeting HIV-1 reverse transcriptase (Q27683249) (← links)
- Irregularities in enzyme assays: The case of macrophage migration inhibitory factor (Q27704828) (← links)
- Prediction of Binding Affinities for TIBO Inhibitors of HIV-1 Reverse Transcriptase Using Monte Carlo Simulations in a Linear Response Method (Q28468206) (← links)
- A Fluorescence Polarization Assay for Binding to Macrophage Migration Inhibitory Factor and Crystal Structures for Complexes of Two Potent Inhibitors (Q28830113) (← links)
- A five-site model for liquid water and the reproduction of the density anomaly by rigid, nonpolarizable potential functions (Q29031294) (← links)
- Prediction of the water content in protein binding sites (Q30495095) (← links)
- Prediction of drug solubility from structure (Q30829138) (← links)
- Polypeptide folding using Monte Carlo sampling, concerted rotation, and continuum solvation (Q30899501) (← links)
- From docking false-positive to active anti-HIV agent (Q33301713) (← links)
- Search for non-nucleoside inhibitors of HIV-1 reverse transcriptase using chemical similarity, molecular docking, and MM-GB/SA scoring (Q33303221) (← links)
- Discovery of wild-type and Y181C mutant non-nucleoside HIV-1 reverse transcriptase inhibitors using virtual screening with multiple protein structures (Q33635679) (← links)
- Quantum mechanical/molecular mechanical modeling finds Diels-Alder reactions are accelerated less on the surface of water than in water (Q33743924) (← links)
- Potential energy functions for atomic-level simulations of water and organic and biomolecular systems (Q33784252) (← links)
- Relationship between side chain structure and 14-helix stability of beta3-peptides in water (Q33862294) (← links)
- Advances in quantum and molecular mechanical (QM/MM) simulations for organic and enzymatic reactions (Q33892565) (← links)
- Eastern extension of azoles as non-nucleoside inhibitors of HIV-1 reverse transcriptase; cyano group alternatives (Q33892766) (← links)
- Evaluation of CM5 Charges for Condensed-Phase Modeling. (Q33893547) (← links)
- Thorpe-Ingold acceleration of oxirane formation is mostly a solvent effect (Q33944377) (← links)
- Vancomycin analogs: Seeking improved binding of d-Ala-d-Ala and d-Ala-d-Lac peptides by side-chain and backbone modifications (Q33944429) (← links)
- Energetic effects for observed and unobserved HIV-1 reverse transcriptase mutations of residues L100, V106, and Y181 in the presence of nevirapine and efavirenz (Q33982889) (← links)
- Exploring solvent effects upon the Menshutkin reaction using a polarizable force field (Q33989438) (← links)
- Biochemical assays for the discovery of TDP1 inhibitors (Q34021070) (← links)
- Optimization of N-benzyl-benzoxazol-2-ones as receptor antagonists of macrophage migration inhibitory factor (MIF) (Q34127116) (← links)
- E/Z Energetics for Molecular Modeling and Design (Q34146465) (← links)
- The many roles of computation in drug discovery (Q34307063) (← links)
- Synthesis and Evaluation of Selected Key Methyl Ether Derivatives of Vancomycin Aglycon (Q34308628) (← links)
- Receptor agonists of macrophage migration inhibitory factor (Q34340164) (← links)
- Why urea eliminates ammonia rather than hydrolyzes in aqueous solution (Q34369975) (← links)
- Polarization Effects for Hydrogen-Bonded Complexes of Substituted Phenols with Water and Chloride Ion (Q34373691) (← links)
- Molecular modeling of organic and biomolecular systems using BOSS and MCPRO. (Q34456227) (← links)
- Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field (Q34459931) (← links)
- Picomolar Inhibitors of HIV-1 Reverse Transcriptase: Design and Crystallography of Naphthyl Phenyl Ethers (Q34519713) (← links)
- Effects of Water Placement on Predictions of Binding Affinities for p38α MAP Kinase Inhibitors (Q34530495) (← links)
- Automated ligand- and structure-based protocol for in silico prediction of human serum albumin binding (Q34615145) (← links)
- Aryl Extensions of Thienopyrimidinones as Fibroblast Growth Factor Receptor 1 Kinase Inhibitors (Q34812867) (← links)
- Benzisothiazolones as modulators of macrophage migration inhibitory factor (Q35114713) (← links)
- Molecular dynamics and Monte Carlo simulations for protein-ligand binding and inhibitor design (Q35117666) (← links)
- Structure-based evaluation of non-nucleoside inhibitors with improved potency and solubility that target HIV reverse transcriptase variants (Q35228851) (← links)